Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Casellas

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Infection|November 1, 1989
Incidence of strains producing extended spectrum beta-lactamases in ArgentinaJ M Casellas, M Goldberg
Journal of Chemotherapy (Florence, Italy)|December 15, 2007
Comparative in vitro activity of tigecycline against aerobic and facultative isolates recovered from hospitalized patients: an Argentinean multicenter studyJ M Casellas, C Bantar, F Duret, et al.
Infectious Disease Clinics of North America|March 1, 1994
The sleeping giant. Antimicrobial resistanceJ M Casellas, M G Blanco, M E Pinto
Chemotherapy|May 25, 2006
Review of pharmacokinetic, pharmacodynamic and clinical studies with a modern combination of amoxicillin/sulbactamJ Soutric, C Bantar, N Caruso, et al.
Infectious Disease Clinics of North America|March 30, 2000
Bacterial resistance to antimicrobial agents in Latin America. The giant is awakeningM Guzmán-Blanco, J M Casellas, H S Sader
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2001
Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific regionP L Winokur, R Canton, J M Casellas, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1996
Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamasesA Bauernfeind, I Stemplinger, R Jungwirth, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 25, 2007
Prevalence of extended-spectrum beta-lactamases in South AmericaM V Villegas, J N Kattan, M G Quinteros, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|July 12, 2001
[Escherichia coli eradication from the blader urine by amoxicillin-sulbactam. Intrinsic activity of the inhibitor]J M Casellas, M Visser, G Tomé, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|December 26, 2001
[Multicenter study in southern South America of the in vitro activity of telithromycin in strains with defined resistance phenotypes isolated from community-acquired respiratory infections]J M Casellas, M Visser, N Mac Dougall, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Infection|November 1, 1989
Incidence of strains producing extended spectrum beta-lactamases in ArgentinaJ M Casellas, M Goldberg
Journal of Chemotherapy (Florence, Italy)|December 15, 2007
Comparative in vitro activity of tigecycline against aerobic and facultative isolates recovered from hospitalized patients: an Argentinean multicenter studyJ M Casellas, C Bantar, F Duret, et al.
Infectious Disease Clinics of North America|March 1, 1994
The sleeping giant. Antimicrobial resistanceJ M Casellas, M G Blanco, M E Pinto
Chemotherapy|May 25, 2006
Review of pharmacokinetic, pharmacodynamic and clinical studies with a modern combination of amoxicillin/sulbactamJ Soutric, C Bantar, N Caruso, et al.
Infectious Disease Clinics of North America|March 30, 2000
Bacterial resistance to antimicrobial agents in Latin America. The giant is awakeningM Guzmán-Blanco, J M Casellas, H S Sader
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 26, 2001
Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific regionP L Winokur, R Canton, J M Casellas, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1996
Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamasesA Bauernfeind, I Stemplinger, R Jungwirth, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 25, 2007
Prevalence of extended-spectrum beta-lactamases in South AmericaM V Villegas, J N Kattan, M G Quinteros, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|July 12, 2001
[Escherichia coli eradication from the blader urine by amoxicillin-sulbactam. Intrinsic activity of the inhibitor]J M Casellas, M Visser, G Tomé, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|December 26, 2001
[Multicenter study in southern South America of the in vitro activity of telithromycin in strains with defined resistance phenotypes isolated from community-acquired respiratory infections]J M Casellas, M Visser, N Mac Dougall, et al.
Pageof 3